Conditions and Requirements. 6.1 Project-specific special conditions and requirements 1. The planned costs for the CSO position in the amount of €109,371.25 can only be charged for activities of one CSO. These costs can neither be reclassified nor used as part of other personnel costs. 2. The costs of the evaluation license, storage and shipments are covered by the overhead flat rate. 3. Travel expenses for quality audits and reaudits are not eligible. 4. The funding of further application possibilities of the Vaxwave technology platform is only provided after at least one field of application (infectious diseases or oncology) has been successfully completed. 6.2 The originally signed Funding Contract must be returned to the Funding Agency no later than 4 weeks after receipt. 6.3 By signing this Funding Contract, the Funding Recipient undertakes to inform the Funding Agency—in the course of the planned reports at the latest—of all applied for and/or approved public grants that directly or indirectly concern the project.
Appears in 2 contracts
Sources: Funding Contract (HOOKIPA Pharma Inc.), Funding Contract (HOOKIPA Pharma Inc.)